Get the Stockscreener App
46.85
1.65%
0.76
After Hours:
46.85
Praxis Precision Medicines Inc stock is traded at $46.85, with a volume of 355.26K.
It is up +1.65% in the last 24 hours and down -1.97% over the past month.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
See More
Previous Close:
$46.09
Open:
$46.58
24h Volume:
355.26K
Relative Volume:
0.87
Market Cap:
$985.99M
Revenue:
$1.77M
Net Income/Loss:
$-123.74M
P/E Ratio:
-5.1091
EPS:
-9.17
Net Cash Flow:
$-95.21M
1W Performance:
+2.88%
1M Performance:
-1.97%
6M Performance:
+23.78%
1Y Performance:
-20.65%
1-Day Range:
$45.81
$47.83
1-Week Range:
$44.13
$47.83
52-Week Range:
$26.70
$91.83
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
Name
Praxis Precision Medicines Inc
Sector
Industry
Phone
617-300-8460
Address
99 HIGH STREET, 30TH FLOOR, BOSTON
Compare PRAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRAX
Praxis Precision Medicines Inc
|
46.85 | 970.00M | 1.77M | -123.74M | -95.21M | -9.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-07-25 | Initiated | Chardan Capital Markets | Buy |
| Mar-03-25 | Reiterated | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Aug-05-24 | Initiated | Oppenheimer | Outperform |
| Jun-24-24 | Initiated | Needham | Buy |
| Jun-18-24 | Initiated | Guggenheim | Buy |
| May-01-24 | Initiated | Robert W. Baird | Outperform |
| Sep-19-23 | Initiated | Truist | Buy |
| Jun-06-22 | Downgrade | Wedbush | Outperform → Neutral |
| Dec-16-21 | Initiated | H.C. Wainwright | Buy |
| Aug-26-21 | Initiated | BofA Securities | Buy |
| Apr-26-21 | Initiated | William Blair | Outperform |
| Nov-11-20 | Initiated | Wedbush | Outperform |
| Nov-10-20 | Initiated | Cowen | Outperform |
| Nov-10-20 | Initiated | Evercore ISI | Outperform |
| Nov-10-20 | Initiated | Piper Sandler | Overweight |
View All
Praxis Precision Medicines Inc Stock (PRAX) Latest News
Should you wait for a breakout in Praxis Precision Medicines Inc.Market Performance Summary & Verified Technical Signals - Newser
What makes Praxis Precision Medicines Inc. stock price move sharplyJuly 2025 Retail & Daily Oversold Bounce Ideas - Newser
What earnings revisions data tells us about Praxis Precision Medicines Inc.2025 Sector Review & Low Risk High Reward Ideas - Newser
Will Praxis Precision Medicines Inc. benefit from macro trendsJuly 2025 Trends & High Conviction Trade Alerts - Newser
How to use a screener to detect Praxis Precision Medicines Inc. breakouts2025 Market Trends & High Accuracy Buy Signal Tips - Newser
Analyzing drawdowns of Praxis Precision Medicines Inc. with statistical tools2025 Volatility Report & Technical Entry and Exit Tips - Newser
Is Praxis Precision Medicines Inc. trending in predictive chart modelsPortfolio Return Summary & Fast Gain Stock Trading Tips - Newser
Using R and stats models for Praxis Precision Medicines Inc. forecastingDollar Strength & Growth Oriented Trade Recommendations - Newser
Risk adjusted return profile for Praxis Precision Medicines Inc. analyzedAnalyst Downgrade & Accurate Buy Signal Alerts - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - FinancialContent
How does Praxis Precision Medicines Inc. score in quality rankingsJuly 2025 Gainers & Verified Chart Pattern Signals - خودرو بانک
Will Praxis Precision Medicines Inc. outperform during market ralliesForecast Cut & Low Risk High Reward Ideas - خودرو بانک
Why is Praxis Precision Medicines Inc. stock going downJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - خودرو بانک
Invesco Ltd. Sells 75,305 Shares of Praxis Precision Medicines, Inc. $PRAX - Defense World
Analysts Set Expectations for PRAX Q3 Earnings - Defense World
Praxis Precision Medicines ends ATM agreement with Jefferies, initiates new $250 million program with TD Cowen - Investing.com South Africa
Strategic Shift in Capital Raising: Praxis Precision Medicines' Transition from Jefferies to TD Securities - AInvest
Praxis Precision Medicines terminates 2024 sales agreement with JefferiesSEC filing - MarketScreener
Praxis Precision Medicines Signs New Sales Agreement - TipRanks
SEC Form 424B5 filed by Praxis Precision Medicines Inc. - Quantisnow
Can swing trading help recover from Praxis Precision Medicines Inc. losses2025 Stock Rankings & AI Enhanced Execution Alerts - Newser
Will Praxis Precision Medicines Inc. benefit from current market trends2025 Macro Impact & Smart Swing Trading Alerts - خودرو بانک
Has Praxis Precision Medicines Inc. formed a bullish divergenceWeekly Investment Report & Safe Entry Point Identification - Newser
Smart tools for monitoring Praxis Precision Medicines Inc.’s price actionMarket Rally & Verified Momentum Stock Watchlist - Newser
Comparing Praxis Precision Medicines Inc. in custom built stock radarsGap Down & Community Driven Trade Alerts - Newser
Reversal indicators forming on Praxis Precision Medicines Inc. stockPortfolio Gains Report & High Win Rate Trade Alerts - Newser
What MACD signals say about Praxis Precision Medicines Inc.Earnings Risk Report & Community Verified Trade Alerts - Newser
Praxis Precision Medicines to Participate in September Investor Conferences - GlobeNewswire
Praxis Precision Medicines to Participate in September Investor Conferences | PRAX Stock News - GuruFocus
Bragar Eagel & Squire, P.C. Is Investigating Praxis, Align, - GlobeNewswire
Praxis Precision Medicines to Present at Upcoming Investor Conferences in September 2025 - Quiver Quantitative
CNS Drug Developer Praxis Precision Medicines Set for Baird, Wainwright, and TD Cowen Conferences - Stock Titan
What candlestick patterns are forming on Praxis Precision Medicines Inc.Portfolio Performance Summary & Stepwise Trade Execution Plans - Newser
How sentiment analysis helps forecast Praxis Precision Medicines Inc.Portfolio Risk Summary & Community Driven Trade Alerts - Newser
Short interest data insights for Praxis Precision Medicines Inc.Profit Target & AI Based Trade Execution Alerts - Newser
Order flow analysis tools used on Praxis Precision Medicines Inc.Trade Risk Summary & Short-Term High Return Ideas - Newser
Sector ETF performance correlation with Praxis Precision Medicines Inc.Market Movement Recap & Detailed Earnings Play Alerts - Newser
Will Praxis Precision Medicines Inc. benefit from rate cutsTrade Entry Report & Smart Allocation Stock Reports - خودرو بانک
How does Praxis Precision Medicines Inc. perform in inflationary periods2025 Price Action Summary & Weekly Sector Rotation Insights - خودرو بانک
Praxis Precision Medicines’ Strategic Talent Acquisition and Equity Incentive Structure - AInvest
Does Praxis Precision Medicines Inc. fit your quant trading modelWeekly Trade Analysis & Reliable Volume Spike Trade Alerts - Newser
Does Praxis Precision Medicines Inc. outperform in volatile marketsPortfolio Update Report & Reliable Entry Point Alerts - خودرو بانک
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
CNS Drug Developer Praxis Precision Medicines Issues 6,238 RSUs Under 2024 Inducement Plan - Stock Titan
Can Praxis Precision Medicines Inc. keep up with sector leaders2025 Volatility Report & Accurate Entry and Exit Point Alerts - خودرو بانک
How to manage a losing position in Praxis Precision Medicines Inc.Volume Spike & Verified Chart Pattern Signals - Newser
Praxis Precision Medicines Inc. stock chart pattern explainedWeekly Trade Recap & AI Based Buy/Sell Signal Reports - Newser
Is Praxis Precision Medicines Inc. a speculative investmentJuly 2025 Summary & Stepwise Trade Signal Guides - خودرو بانک
Praxis Precision Medicines Inc Stock (PRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Praxis Precision Medicines Inc Stock (PRAX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Nemiroff Alex | General Counsel and Secretary |
Nov 14 '24 |
Sale |
80.20 |
8,239 |
660,827 |
10,301 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Option Exercise |
56.94 |
4,374 |
249,056 |
10,801 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Sale |
81.78 |
5,188 |
424,318 |
5,613 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):